8 in 1

• Methylprednisolone
• Dacarbazine
• Lomustine
• Cisplatin
• Procarbazine
• Cytarabine
• Hydroxyurea
• Vincristine

Name

Methylprednisolone

Alternate Names

A-Methapred

Cordex Forte

Depmedalone

Depo-Medrol

Depo-Predate

Depoject

Depopred

Dopmedrol

Enpak Refill

Mar-Pred

Medrate

Medrol

Medrone

Methyl Prednisolone

Methylone

Pre-Dep

Promacortine

Rep-Pred

Urbason

Abbreviations

None

Category

Hormones and hormonal mechanisms

Subcategory

Glucocorticoid

NSC Number

019987

19987

Primary Site

None

Histology

None

Remarks

Code this drug as hormone therapy when given in multi-drug regimens.

Coding

This drug should be coded

Name

Dacarbazine

Alternate Names

Deticene

Detimedac

Dimethyl-triazeno-imidazole-carboxamide

DTIC-Dome

Fauldetic

Imidazole carboxamide

WR-139007

Abbreviations

DIC

DTIC

ICDT

ICT

Category

Chemotherapy

Subcategory

Antimetabolite

Nonclassic alkylating agent

NSC Number

45388

045388

Primary Site

Hodgkin's disease

melanoma

Neuroblastoma

Soft tissue sarcomas

Histology

None

Remarks

FDA approved on Hodgkin's lymphoma, and metastatic melanoma.

Coding

This drug should be coded

Name

Lomustine

Alternate Names

Belustine (nitrosourea)

CeeNu

Chloroethylcyclohexylnitrosourea

ICIG 1109

RB1509

WR-139017

Abbreviations

CCNU

Category

Chemotherapy

Subcategory

Alkylating agent

NSC Number

079037

79037

Primary Site

Brain tumors: primary or metastatic

Hodgkin lymphoma

Non-Hodgkin lymphoma

Histology

None

Remarks

Cell-cycle nonspecific antineoplastic agent;alkylating agent. FDA approved uses in brain tumor and Hodgkin's lymphoma.

Coding

This drug should be coded

Name

Cisplatin

Alternate Names

Cis-Platin

Cis-Platinum II#

Cisplatino (Spanish)

Cisplatinum

Cisplatyl

Neoplatin

Peyrone's chloride

Platinex

Platinol

Platinol-AQ

Platinol-AQ VHA Plus

Platinum

Abbreviations

CACP

CDDP

Cis-DDP

CPD

CPDC

CPDD

CPPD

DDP

Category

Chemotherapy

Subcategory

Alkylating agent

Platinum analog

NSC Number

119875

Primary Site

Bladder

ovarian

testicular cancer

Histology

None

Remarks

An alkylating antineoplastic agent. FDA approved uses on bladder, ovarian and testicular cancer; miscellaneous agent.

Coding

This drug should be coded

Name

Procarbazine

Alternate Names

Ibenzmethyzin Hydrochloride

Matulane

Methylhydrazine

N-Methylhydrazine

Natulan

Natulane

Procarbazine hydrochloride

Ro-4-6467

Ro4-6467/1

Abbreviations

IBZ

MIH

PCB

PCH

PCI

PCZ

Category

Chemotherapy

Subcategory

Nonclassic alkylating agent

NSC Number

077213

77213

Primary Site

Brain tumors adjuvant and/or advanced disease

Cutaneous T-cell lymphoma

Hodgkin lymphoma

Non-Hodgkin lymphoma

Histology

None

Remarks

An orally administered hydrazine derivative antineoplastic agent. FDA approved in stages III, IV Hodgkin's lymphoma.

Coding

This drug should be coded

Name

Cytarabine

Alternate Names

AC-1075

Alexan

Ara-cytidine

Arabinocytidine

Arabinosylcytosine

Beta-Arabinosylcytosine

Cytarabin

Cytarabine

Cytarabinoside

Cytosar

Cytosar-U

Cytosine Arabinoside

Cytosine arabinoside hydrochloride

Spongocytidine HCL

Tarabine

Tarabine PFS

U-19920

U-19920A

WR-28453

Abbreviations

ara-C

CA

HDA

HDARA-C

Category

Chemotherapy

Subcategory

Antimetabolite

NSC Number

063878

63878

Primary Site

ALL

AML

CML

head and neck

Hodgkin's disease

leukemia

Meningeal leukemia

NHL

Histology

None

Remarks

Antineoplastic agent; antimetabolite. FDA approved uses on Hodgkin's disease, leukemia; under investigation for Rx of Progressive Multifocal Leukoencephalopathy (PML)

Coding

This drug should be coded

Name

Hydroxyurea

Alternate Names

Carbamo-hydroximic acid

Carbamohydroxamic acid

Carbamoyl oxime

Droxia

Hidrix

Hydrea

Hydreia

hydroxy-

Hydroxycarbamide

Hydroxycarbamine

Hydroxyl-urea

Hydura

Litaler

Litalir

Onco-Carbide

Oxyurea

SQ-1089

Urea

WR-83799

Abbreviations

HU

HUR

HYD

Category

Chemotherapy

Subcategory

Miscellaneous agent

NSC Number

032065

32065

Primary Site

Brain cancer

CML

Head and neck cancers

Melanoma

Ovarian cancer

Essential thrombocytosis

Polycythemia Vera

Histology

None

Remarks

FDA approved uses on chronic myelogenous leukemia, head and neck cancers, melanoma, and advanced ovarian cancer.

Coding

This drug should be coded

Name

Vincristine

Alternate Names

Compound 37231

Leurocristine Sulfate

Oncovin

Vincasar

Vincasar PFS

Vincristine Sulfate

Vincrystine

Vinkristin

Abbreviations

LCR

VCR

VNCR

Category

Chemotherapy

Subcategory

Plant alkyloid--antimetabolite

NSC Number

067574

67574

Primary Site

None

Histology

None

Remarks

Antineoplastic; vinca plant alkaloid; antimetabolite. FDA approved uses in ALL, Hodgkin's lymphoma, non-Hodgkin's lymphoma, neuroblastoma, rhabomyosarcoma, and Wilm's tumor.

Coding

This drug should be coded